 encourage pharmaceutical companies and investors to support transplant. So I think we need an outcome that measures something important to patients, which is a longer term outcome, as well as a quality of life outcome. And Bill, in the last minute, what would you like to see happen? What's the most important thing that you think would be significant going forward?